| For: | Singh P, Kairuz D, Arbuthnot P, Bloom K. Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approach. World J Gastroenterol 2021; 27(23): 3182-3207 [PMID: 34163105 DOI: 10.3748/wjg.v27.i23.3182] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v27/i23/3182.htm |
| Number | Citing Articles |
| 1 |
Prashika Singh, Tafadzwa Mlambo, Kristie Bloom, Claudio Mussolino, Patrick Arbuthnot, Abdullah Ely. RNA Therapeutics. Methods in Molecular Biology 2025; 2965 doi: 10.1007/978-1-0716-4742-4_15
|
| 2 |
Patricia Gita Naully, Marselina Irasonia Tan, Husna Nugrahapraja, Aluicia Anita Artarini, Reza Aditama, Ernawati Arifin Giri-Rachman, Sheikh Arslan Sehgal. Design of multi-epitope-based therapeutic vaccine candidates from HBc and HBx proteins of hepatitis B virus using reverse vaccinology and immunoinformatics approaches. PLOS ONE 2024; 19(12) doi: 10.1371/journal.pone.0313269
|
| 3 |
Rachel Matrenec, Claudia E. Oropeza, Eddie Dekoven, Carly Matrenec, Mark Maienschein-Cline, Cecilia S. Chau, Stefan J. Green, Klaus H. Kaestner, Alan McLachlan, Jae U. Jung. Foxa deficiency restricts hepatitis B virus biosynthesis through epigenic silencing. Journal of Virology 2024; 98(11) doi: 10.1128/jvi.01371-24
|
| 4 |
Samrita Naidu, Severine Margeridon. Chronic Hepatitis B Virus Persistence: Mechanisms and Insights. Cureus 2025; doi: 10.7759/cureus.78944
|
| 5 |
Liqiong Yang, Tao Zou, Yao Chen, Yueshui Zhao, Xu Wu, Mingxing Li, Fukuan Du, Yu Chen, Zhangang Xiao, Jing Shen. Hepatitis B virus X protein mediated epigenetic alterations in the pathogenesis of hepatocellular carcinoma. Hepatology International 2022; 16(4) doi: 10.1007/s12072-022-10351-6
|
| 6 |
Patricia Gita Naully, Marselina Irasonia Tan, Agustiningsih Agustiningsih, Caecilia Sukowati, Ernawati Arifin Giri-Rachman. cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B. Annals of Hepatology 2025; 30(1) doi: 10.1016/j.aohep.2024.101533
|
| 7 |
Renato Bobadilla, Finn MacLean, Shravan Dave, Jason Blackard, Sara Gianella. Hepatic Viral Reservoirs in Concurrent HIV and HBV: From Mechanistic Insight to Integrated Cure Strategies. Infection and Drug Resistance 2026; doi: 10.2147/IDR.S576715
|
| 8 |
Jihua Ren, Shengtao Cheng, Fang Ren, Huiying Gu, Daiqing Wu, Xinyan Yao, Ming Tan, Ailong Huang, Juan Chen. Epigenetic regulation and its therapeutic potential in hepatitis B virus covalently closed circular DNA. Genes & Diseases 2025; 12(1) doi: 10.1016/j.gendis.2024.101215
|
| 9 |
Mark A. Feitelson, Alla Arzumanyan, Ira Spector, Arvin Medhat. Hepatitis B x (HBx) as a Component of a Functional Cure for Chronic Hepatitis B. Biomedicines 2022; 10(9) doi: 10.3390/biomedicines10092210
|
| 10 |
Johannes Bächer, Lena Allweiss, Maura Dandri. SMC5/6-Mediated Transcriptional Regulation of Hepatitis B Virus and Its Therapeutic Potential. Viruses 2024; 16(11) doi: 10.3390/v16111667
|
| 11 |
Nadiia Kasianchuk, Krystyna Dobrowolska, Sofiia Harkava, Andreea Bretcan, Dorota Zarębska-Michaluk, Jerzy Jaroszewicz, Robert Flisiak, Piotr Rzymski. Gene-Editing and RNA Interference in Treating Hepatitis B: A Review. Viruses 2023; 15(12) doi: 10.3390/v15122395
|
| 12 |
Ulrike M. Reiss, Johnny Mahlangu, Tsukasa Ohmori, Margareth C. Ozelo, Alok Srivastava, Lei Zhang. Haemophilia gene therapy—Update on new country initiatives. Haemophilia 2022; 28(S4) doi: 10.1111/hae.14512
|
| 13 |
Gavin J. Marcoe, Clairine I. S. Larsen, Monnette F. Summers, Kinjal Majumder, Guangxiang George Luo. Association of hepatitis B virus genomes with active chromatin hubs challenges host replication fidelity, leading to DNA damage. Journal of Virology 2025; 99(11) doi: 10.1128/jvi.01014-25
|
| 14 |
Patricia Gita Naully, Marselina Irasonia Tan, Korri Elvanita El Khobar, Caecilia H C Sukowati, Ernawati Arifin Giri-Rachman. Advancing therapeutic vaccines for chronic hepatitis B: Integrating reverse vaccinology and immunoinformatics. World Journal of Hepatology 2025; 17(7): 107620 doi: 10.4254/wjh.v17.i7.107620
Abstract(416) |
Core Tip(391) |
Full Article(HTML)(1441)
|
Full Article (PDF)-1331K(159)
|
Full Article with Cover (PDF)-1555K(84)
|
Full Article (XML)-265K(75)
|
Audio-7304K(19)
|
Peer-Review Report-234K(83)
|
Answering Reviewers-125K(81)
|
Supplementary Material-369K(64)
|
Times Cited (0)
|
Total Visits (2421)
|
Open
|
| 15 |
S. Yao, K. Prates, A. Freydenzon, G. Assante, A. F. McRae, M. J. Morris, N. A. Youngson. Liver‐specific deletion of de novo DNA methyltransferases protects against glucose intolerance in high‐fat diet‐fed male mice. The FASEB Journal 2024; 38(10) doi: 10.1096/fj.202301546RR
|
| 16 |
Lottida Phondeth, Thomas Tu. Biology of hepatitis B virus DNA integration and its impact on antiviral R&D. Antiviral Research 2025; 244 doi: 10.1016/j.antiviral.2025.106305
|
| 17 |
Dylan Kairuz, Prashika Singh, Tiffany Smith, Patrick Arbuthnot, Abdullah Ely, Kristie Bloom. Messenger RNA Therapeutics. RNA Technologies 2022; 13 doi: 10.1007/978-3-031-08415-7_8
|
| 18 |
Mohube B. Maepa, Abdullah Ely, Anna Kramvis, Kristie Bloom, Kubendran Naidoo, Omphile E. Simani, Tongai G. Maponga, Patrick Arbuthnot. Hepatitis B Virus Research in South Africa. Viruses 2022; 14(9) doi: 10.3390/v14091939
|